NCT06196177View on ClinicalTrials.gov

Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure

PHASE4RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2025

Conditions
Heart FailureAortic Stenosis, Severe
Interventions
DRUG

Levosimontane injection

Levosimendan injection was given once intravenously with a micro-pump: 12.5mg levosimendan injection was diluted with 5% glucose injection to 50ml at the initial pump speed of 2ml/h for 24h.

Trial Locations (1)

250000

RECRUITING

QIlu hospital of shandong university, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER